Last updated on February 2018

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer


Brief description of study

The main purpose of this study is to compare how long patients with gastric or gastroesophageal junction cancer live after receiving nivolumab and ipilimumab or nivolumab and chemotherapy compared with patients receiving chemotherapy alone.

Clinical Study Identifier: NCT02872116

Contact Investigators or Research Sites near you

Start Over

Site 0185

Local Institution
Fuzhou, China
  Connect »